These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 33202285)
21. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383 [TBL] [Abstract][Full Text] [Related]
22. Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota. Wang D; Zeng J; Wujin C; Ullah Q; Su Z Microb Pathog; 2024 Mar; 188():106541. PubMed ID: 38224920 [TBL] [Abstract][Full Text] [Related]
23. The prevention effect of Limosilactobacillus reuteri on acute kidney injury by regulating gut microbiota. Yang Z; Ni J; Sun X; Cui Q; Zhang X; Zhang M; Zhu X; Wu Z; Tang C; Zhu J; Mao H; Liu K; Wang C; Xing C; Zhu J Microbiol Immunol; 2024 Jul; 68(7):213-223. PubMed ID: 38747013 [TBL] [Abstract][Full Text] [Related]
24. Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice. Yuan C; Fan J; Jiang L; Ye W; Chen Z; Wu W; Huang Q; Qian L Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904149 [TBL] [Abstract][Full Text] [Related]
25. Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure. Wang LK; Wang LW; Li X; Han XQ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):180-8. PubMed ID: 23558073 [TBL] [Abstract][Full Text] [Related]
26. The therapeutic effect of CORM-3 on acute liver failure induced by lipopolysaccharide/D-galactosamine in mice. Yan BZ; Yang BS; Li H; Zhang YF; Pei FH; Zhu AC; Wang XR; Liu BR Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):73-80. PubMed ID: 26818546 [TBL] [Abstract][Full Text] [Related]
27. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. Liu Y; Fatheree NY; Mangalat N; Rhoads JM Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G608-17. PubMed ID: 22207578 [TBL] [Abstract][Full Text] [Related]
28. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Liu Y; Tran DQ; Fatheree NY; Marc Rhoads J Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G177-86. PubMed ID: 24852566 [TBL] [Abstract][Full Text] [Related]
29. Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice. Sun MC; Zhang FC; Yin X; Cheng BJ; Zhao CH; Wang YL; Zhang ZZ; Hao HW; Zhang TH; Ye HQ J Food Sci; 2018 Oct; 83(10):2645-2652. PubMed ID: 30216448 [TBL] [Abstract][Full Text] [Related]
30. Probiotics Wang T; Zheng N; Luo Q; Jiang L; He B; Yuan X; Shen L Front Immunol; 2019; 10():1235. PubMed ID: 31214189 [TBL] [Abstract][Full Text] [Related]
31. Modulating effects of heat-killed and live Ali MS; Lee EB; Quah Y; Sayem SAJ; Abbas MA; Suk K; Lee SJ; Park SC Vet Q; 2024 Dec; 44(1):1-18. PubMed ID: 38682319 [TBL] [Abstract][Full Text] [Related]
32. Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Osman N; Adawi D; Ahrné S; Jeppsson B; Molin G Dig Liver Dis; 2007 Sep; 39(9):849-56. PubMed ID: 17652039 [TBL] [Abstract][Full Text] [Related]
33. The oral administration of Lv L; Ren S; Jiang H; Yan R; Chen W; Yan R; Dong J; Shao L; Yu Y mSphere; 2024 Jan; 9(1):e0067223. PubMed ID: 38193757 [TBL] [Abstract][Full Text] [Related]
34. Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut. Alghetaa H; Mohammed A; Zhou J; Singh N; Nagarkatti M; Nagarkatti P Pharmacol Res; 2021 May; 167():105548. PubMed ID: 33722710 [TBL] [Abstract][Full Text] [Related]
35. Probiotics and gut health in infants: A preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938. Savino F; Fornasero S; Ceratto S; De Marco A; Mandras N; Roana J; Tullio V; Amisano G Clin Chim Acta; 2015 Dec; 451(Pt A):82-7. PubMed ID: 25704298 [TBL] [Abstract][Full Text] [Related]
36. Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling. Zhang L; Gong X; Tan J; Zhang R; Li M; Liu C; Wu C; Li X Biol Direct; 2024 Mar; 19(1):23. PubMed ID: 38500127 [TBL] [Abstract][Full Text] [Related]
37. Effects of Limosilactobacillus reuteri strains PTA-126787 and PTA-126788 on intestinal barrier integrity and immune homeostasis in an alcohol-induced leaky gut model. Gangaiah D; Gu M; Zaparte A; Will O; Dolan LC; Goering A; Pillai J; Mane SP; Plata G; Helmes EB; Welsh DA; Mahajan AK Sci Rep; 2024 Aug; 14(1):19584. PubMed ID: 39179898 [TBL] [Abstract][Full Text] [Related]
38. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Yu L; Zhao XK; Cheng ML; Yang GZ; Wang B; Liu HJ; Hu YX; Zhu LL; Zhang S; Xiao ZW; Liu YM; Zhang BF; Mu M Sci Rep; 2017 May; 7(1):1359. PubMed ID: 28465509 [TBL] [Abstract][Full Text] [Related]
39. Identification of differentially expressed miRNAs after Lactobacillus reuteri treatment in the ileum mucosa of piglets. Wang Q; Sun Q; Wang J; Qiu X; Qi R; Huang J Genes Genomics; 2020 Nov; 42(11):1327-1338. PubMed ID: 32980994 [TBL] [Abstract][Full Text] [Related]
40. Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes. Li L; Fang Z; Liu X; Hu W; Lu W; Lee YK; Zhao J; Zhang H; Chen W PLoS One; 2020; 15(4):e0231865. PubMed ID: 32315360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]